GSK to buy liver disease drug from Boston Pharmaceuticals for up to $2 billionGSK is set to acquire efimosfermin, a promising liver disease drug, from Boston Pharmaceuticals for a potential $2 billion. The deal includ...
14 May, 2025, 01.52 PM IST
GSK boosts respiratory portfolio with $1.4 bn Aiolos Bio dealGSK will pay $1 billion upfront and up to $400 million in certain success-based regulatory milestone payments. It will also make milestone ...
09 Jan, 2024, 05.43 PM IST
Sun Pharma inks licensing pact with SPARC to commercialise medication in US marketSPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for the said product in February 2022.
09 Nov, 2022, 02.30 PM IST
Pfizer to buy 8.1% stake in French vaccines company ValnevaValneva will use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program. ...
20 Jun, 2022, 11.51 AM IST
Persistent bets on IP revenue to maintain its Q3 marginsThe Pune headquartered mid-tier IT company is among the few software exporters to report a sequential revenue growth in the June as well as...
27 Oct, 2020, 07.46 AM IST
Govt to study auto supply chain to boost localisationThe move follows a meeting between commerce & industry minister Piyush Goyal and senior auto industry representatives on August 13 to delib...
22 Aug, 2020, 12.04 AM IST
Enabling provision for mandatory hallmarking of gold kicks in from October 12Currently, hallmarking of jewellery is voluntary, with just 20000 of 3 lakh jewellers countrywide having a BIS license, said sources.
14 Oct, 2017, 05.29 PM IST
AstraZeneca sells ageing beta-blocker to Recordati for $300 mlnAstraZeneca, which retains rights to the beta-blocker outside Europe, will continue to manufacture and ship product to Recordati under a su...
22 May, 2017, 01.46 PM IST
Sun Pharma completes acquisition of Ocular Technologies SarlAll the necessary formalities for closure of the said transaction have been concluded and the company has successfully completed the acquis...
16 Dec, 2016, 11.36 AM IST
Sun Pharma, Moebius Medical to develop osteoarthritis pain productMM-II is an intra-articular bio lubricant injection which is being developed to provide symptomatic relief of mild-to-moderate osteoarthrit...
12 Dec, 2016, 05.33 PM IST
Civil aviation policy: AirAsia, Vistara biggest beneficiaries of 5/20 rule changeNow an airline has to scale its fleet up to 20 planes or deploy 20% of capacity on domestic operations, whichever is higher, to qualify for...
16 Jun, 2016, 03.21 AM IST
Alembic Pharma arm ties up with Novartis for drug developmentAlembic Pharmaceuticals group firm Rhizen Pharmaceuticals SA has entered into an exclusive worldwide license agreement with Novartis.
10 Dec, 2015, 03.17 PM IST
Pizza chain Sbarro to open 40 outlets in India by 2019US-based Pizza chain Sbarro is planning to open 40 'New York pizza' restaurants in north and east India as part of its expansion plans.
24 Sep, 2014, 11.27 AM IST
Nasscom for extension of sops to IT companies in non-metro citiesThe sops being given to the IT firms in metro cities should be extended to companies in tier 2 and 3 cities to boost growth, Nasscom has sa...
12 Jun, 2014, 08.11 PM IST
- Hero Honda shares tank on JV termination report
Hero Corporate will buy 26 percent of Honda's stake in the joint venture for $1 billion to $1.2 billion.
15 Dec, 2010, 02.31 PM IST
- In two-tier checks, govt plans state regulator for minor minerals
The government proposes to form a state mining regulatory authority to cover minor minerals that are used in the small scale sector, as par...
02 Oct, 2010, 03.37 AM IST
- States to run all new metro rail projects
In a major policy shift, the govt has decided to operationalise all future urban metro projects under the tested build-operate-transfer mod...
30 Aug, 2008, 12.19 AM IST